Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11Dermatologic 4Lymphoid 2Head & Neck 2Thoracic 1Other 1Gastrointestinal 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6857Lung Neoplasms 5091Small Cell Lung Carcinoma 1162Breast Neoplasms 854Neoplasms 762Colorectal Neoplasms 664Melanoma 566Ovarian Neoplasms 505Neoplasm Metastasis 480Pancreatic Neoplasms 472Stomach Neoplasms 396Adenocarcinoma of Lung 396Prostatic Neoplasms 369Head and Neck Neoplasms 366Carcinoma, Renal Cell 349Esophageal Neoplasms 336Mesothelioma, Malignant 324Squamous Cell Carcinoma of Head and Neck 323Colonic Neoplasms 293Mesothelioma 289Urinary Bladder Neoplasms 262Brain Neoplasms 253Uterine Cervical Neoplasms 241Triple Negative Breast Neoplasms 220Sarcoma 197Endometrial Neoplasms 195Carcinoma, Hepatocellular 185NSCLC 165Kidney Neoplasms 160Pleural Effusion, Malignant 159

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dermatitis × Thoracic × Clear all
NCT02346318 2017-07-21

The Randomized Controlled Clinical Trial of Kushen Injection

Beijing Zheng Ju Medical Technology Co., Ltd.

Phase 4 Unknown
240 enrolled
Thoracic

Dermatitis, Eczema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡